We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
JELD-WEN Holding
JELD
$94.8M
| $257K | ﹤0.01% |
16,233
+4,824
| +42% | +$70.8K |
|
1577
Integra LifeSciences
IART
$1.54B
| $256K | ﹤0.01% |
+14,095
| New | +$327K |
|
1578
ImmunityBio
IBRX
$7.44B
| $255K | ﹤0.01% |
68,512
+8,059
| +13% | +$37.3K |
|
1579
Thor Industries
THO
$3.99B
| $255K | ﹤0.01% |
2,319
-196
| -8% | -$19.9K |
|
1580
InMode
INMD
$872M
| $255K | ﹤0.01% |
15,024
+4,646
| +45% | +$78.4K |
|
1581
CRISPR Therapeutics
CRSP
$4.58B
| $252K | ﹤0.01% |
5,358
-210
| -4% | -$10.7K |
|
1582
Arcutis Biotherapeutics
ARQT
$3.42B
| $251K | ﹤0.01% |
26,984
+9,245
| +52% | +$91.2K |
|
1583
AtriCure
ATRC
$1.77B
| $251K | ﹤0.01% |
+8,945
| New | +$220K |
|
1584
Safety Insurance
SAFT
$1.52B
| $251K | ﹤0.01% |
+3,066
| New | +$252K |
|
1585
Amneal Pharmaceuticals
AMRX
$5.72B
| $250K | ﹤0.01% |
30,069
+13,742
| +84% | +$107K |
|
1586
Matador Resources
MTDR
$6.31B
| $250K | ﹤0.01% |
5,061
-15,599
| -76% | -$878K |
|
|
MTTR
1587
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $249K | ﹤0.01% |
55,432
+15,705
| +40% | +$68.5K |
|
|
LADR
1588
Ladder Capital
LADR
$1.25B
| $249K | ﹤0.01% |
21,453
+6,273
| +41% | +$74.4K |
|
1589
Cohu
COHU
$2.39B
| $248K | ﹤0.01% |
9,668
+2,471
| +34% | +$69.2K |
|
1590
Aurinia Pharmaceuticals
AUPH
$1.97B
| $248K | ﹤0.01% |
33,817
+6,850
| +25% | +$42.5K |
|
1591
Employers Holdings
EIG
$908M
| $247K | ﹤0.01% |
+5,155
| New | +$238K |
|
1592
Nice
NICE
$5.29B
| $247K | ﹤0.01% |
1,422
-374
| -21% | -$64.2K |
|
|
ACH
1593
Accendra Health
ACH
$240M
| $246K | ﹤0.01% |
15,706
+4,292
| +38% | +$65K |
|
|
NVEI
1594
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $246K | ﹤0.01% |
7,382
-288
| -4% | -$9.51K |
|
|
MFA
1595
MFA Financial
MFA
$929M
| $246K | ﹤0.01% |
19,344
+5,633
| +41% | +$66.4K |
|
1596
AppFolio
APPF
$5.85B
| $246K | ﹤0.01% |
1,045
-2,585
| -71% | -$605K |
|
1597
Upwork
UPWK
$1.09B
| $246K | ﹤0.01% |
23,539
-9,979
| -30% | -$104K |
|
|
BORR
1598
Borr Drilling
BORR
$1.31B
| $246K | ﹤0.01% |
44,798
+15,341
| +52% | +$93.8K |
|
1599
MGP Ingredients
MGPI
$378M
| $246K | ﹤0.01% |
+2,953
| New | +$244K |
|
1600
Olin
OLN
$2.64B
| $246K | ﹤0.01% |
5,122
-510
| -9% | -$22.7K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.